Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Simple Search
Search Type:
Include the phrase
Include any of the words
Criteria:
You could also try:
procedure (650)
,
etiquette (1)
,
practice (609)
Letrozole-Palbociclib
Description
Chemotherapy
Protocol
Breast Cancer Letrozole-Palbociclib Regimen • Breast Cancer – Letrozole-Palbociclib Indication • Palbociclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Letrozole-Palbociclib.pdf
Exemestane-Palbociclib
Description
Chemotherapy
Protocol
Breast Cancer Exemestane-Palbociclib Regimen • Breast Cancer – Exemestane-Palbociclib Indication • Palbociclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Exemestane-Palbociclib.pdf
Docetaxel (75) Ver 1.1
Description
Chemotherapy
Protocol
BREAST CANCER DOCETAXEL (75) Regimen Breast Cancer – Docetaxel (75) Indication Treatment of locally advanced or metastatic HER2 positive breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-75-Ver-11.pdf
Cyclophosphamide-Epirubicin (75)-Fluorouracil (FE75C)
Description
Chemotherapy
Protocol
BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (75)- FLUOROURACIL Regimen (FE75C) • Breast Cancer – Cyclophosphamide-Epirubicin (75)-Fluorouracil (FE75C) Indication • Neo-adjuvant / adjuvant
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE75C.pdf
Cyclophosphamide-Epirubicin (60)-Fluorouracil (FE60C)
Description
Chemotherapy
Protocol
BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (60)- FLUOROURACIL Regimen (FE60C) • Breast Cancer – Cyclophosphamide-Epirubicin (60)-Fluorouracil (FE60C) Indication • Metastatic breast cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE60C.pdf
Cyclophosphamide-Epirubicin (100)-Fluorouracil (FE100C)
Description
Chemotherapy
Protocol
BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (100)- FLUOROURACIL Regimen (FE100C) • Breast Cancer – Cyclophosphamide-Epirubicin (100)-Fluorouracil (FE100C) Indication • Neo-adjuvant /adjuvant
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE100C.pdf
Cyclophosphamide (PO)-Fluorouracil-Methotrexate (CMF PO)
Description
Chemotherapy
Protocol
BREAST CANCER CYCLOPHOSPHAMIDE (PO)-FLUOROURACIL-METHOTREXATE (CMF-PO) Regimen • Breast Cancer – Cyclophosphamide (PO)-Fluorouracil-Methotrexate (CMF PO) Indication • Adjuvant
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-PO.pdf
Cyclophosphamide (IV)-Fluorouracil-Methotrexate (CMF IV)
Description
Chemotherapy
Protocol
BREAST CANCER CYCLOPHOSPHAMIDE–FLUOROURACIL-METHOTREXATE (CMF IV) Regimen • Breast Cancer – Cyclophosphamide IV-Fluorouracil-Methotrexate (CMF IV) Indication • Adjuvant treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-IV.pdf
Lomustine-Procarbazine-Vincristine (PCV) ver 1.1
Description
Chemotherapy
Protocol
Central Nervous System LOMUSTINE-PROCARBAZINE-VINCRISTINE (PCV) Regimen CNS – Lomustine-Procarbazine-Vincristine (PCV) Indication Adjuvant treatment for grade III
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-Procarbazine-Vincristine-PCV-ver-1.1.pdf
Irinotecan Mitomycin
Description
Chemotherapy
Protocol
GYNAECOLOGICAL CANCER IRINOTECAN-MITOMYCIN Regimen Ovary-Irinotecan-Mitomycin Indication Platinum refractory clear cell or mucinous ovarian cancer Recurrent platinum
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/IrinotecanMitomycin.pdf
411
to
420
of
698
Previous
…
40
41
42
43
44
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.